CAREFUSION CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 52 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-03-17: Reporting owner Wygant Jonathan; Form 4; Security Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-17: Reporting owner Wygant Jonathan; Form 4; Security Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-17: Reporting owner Wygant Jonathan; Form 4; Security Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-17: Reporting owner Wygant Jonathan; Form 4; Security Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,097 0 owned after | $22.59 exercise price | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,114 0 owned after | $25.56 exercise price | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,182 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,989 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,372 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,024 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −42,331 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −57,439 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | Paolucci Michael E Officer (EVP, Human Resources) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −56,249 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,866 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −55,284 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −80,787 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,378 0 owned after | $20.71 exercise price | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,765 0 owned after | $22.59 exercise price | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,706 0 owned after | $25.56 exercise price | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,926 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −36,890 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −33,372 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −52,276 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −86,501 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −117,375 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −159,464 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −266,430 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −350,997 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,587 0 owned after | $26.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,129 0 owned after | $36.17 exercise price | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,027 0 owned after | $43.97 exercise price | 2015-03-19 | |
| 2015-03-12 | OHALLERAN MICHAEL D Director | 4 | Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,630 0 owned after | $22.35 exercise price | 2015-03-19 | |
| 2015-03-11 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,163 0 owned after | $22.59 exercise price | 2015-03-13 | |
| 2015-03-11 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −76,586 0 owned after | $22.56 exercise price | 2015-03-13 | |
| 2015-03-11 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −61,730 30,866 owned after | $26.79 exercise price | 2015-03-13 | |
| 2015-03-11 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,642 55,284 owned after | $36.17 exercise price | 2015-03-13 | |
| 2015-03-11 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,764 0 owned after | $20.71 exercise price | 2015-03-13 | |
| 2015-03-11 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,630 0 owned after | $22.59 exercise price | 2015-03-13 | |
| 2015-03-11 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −192,574 0 owned after | $24.41 exercise price | 2015-03-13 | |
| 2015-03-11 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −160,187 0 owned after | $25.56 exercise price | 2015-03-13 | |
| 2015-03-11 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −104,550 52,276 owned after | $26.79 exercise price | 2015-03-13 | |
| 2015-03-11 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −43,250 86,501 owned after | $36.17 exercise price | 2015-03-13 | |
| 2015-03-11 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −533,110 0 owned after | $27.84 exercise price | 2015-03-13 | |
| 2015-03-11 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −503,306 0 owned after | $25.56 exercise price | 2015-03-13 | |
| 2015-03-11 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −318,928 159,464 owned after | $26.79 exercise price | 2015-03-13 | |
| 2015-03-11 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −133,215 266,430 owned after | $36.17 exercise price | 2015-03-13 | |
| 2015-03-11 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,016 0 owned after | $22.59 exercise price | 2015-03-13 | |
| 2015-03-11 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −69,207 0 owned after | $25.56 exercise price | 2015-03-13 | |
| 2015-03-11 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −46,046 23,024 owned after | $26.79 exercise price | 2015-03-13 | |
| 2015-03-11 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,165 42,331 owned after | $36.17 exercise price | 2015-03-13 | |
| 2015-03-11 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −39,516 0 owned after | $20.71 exercise price | 2015-03-13 | |
| 2015-03-11 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,377 0 owned after | $22.59 exercise price | 2015-03-13 | |
| 2015-03-11 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,700 0 owned after | $25.56 exercise price | 2015-03-13 | |
| 2015-03-11 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,172 12,587 owned after | $26.79 exercise price | 2015-03-13 | |
| 2015-03-11 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,064 22,129 owned after | $36.17 exercise price | 2015-03-13 | |
| 2015-02-06 | FRANCIS PHILIP L Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,630 0 owned after | $22.35 exercise price | 2015-02-10 |